Meetings

  • Understanding Disparities in Access to Genomic Medicine: A Workshop Date: June 27, 2018 (8:30 AM Eastern)

    The Roundtable on Genomics and Precision Health will host a public workshop on June 27, 2018 to explore disparities in access to genetic/genomic services that exist across different segments of the population (e.g., in medically underserved areas and populations, across different racial/ethnic groups, and socioeconomic levels). The workshop may discuss model programs of care for diverse patient populations, with a focus on examining current challenges, approaches, and best practices for alleviating disparities in access, which may include the geographic distribution of providers and services and the potential role of telemedicine. Workshop discussions may also focus on insurance coverage for genetic/genomic services, along with the financial costs for patients of genetic testing and downstream care.
  • Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors: A Workshop Date: July 16, 2018 - July 17, 2018 (8:00 AM Eastern)

    The National Cancer Policy Forum will hold a public workshop on July 16-17, 2018 to examine the opportunities to improve the clinical development of immune checkpoint inhibitor therapies for cancer, including in the context of site-agnostic indications.
  • Examining the Impact of Real-World Evidence on Medical Product Development: Application Date: July 17, 2018 - July 18, 2018 (8:30 AM Eastern)

    An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM) will plan and conduct a three-part workshop series to be held over the course of a two-year period. As part of FDA's continued focus on building a national governance system for evidence generation, the proposed focus of these workshops will be on the generation and utilization of real-world evidence to evaluate efficacy, effectiveness, tolerability, and safety for both review of new indications and postapproval studies. These workshops would include presentations and perspectives from thought and knowledge leaders representing a range of disciplines, including but not limited to federal regulatory and funding agencies, clinical and academic medicine and research, medical professional organizations, the regulated biopharmaceutical industry, patients and patient-focused and disease-advocacy organizations, payers, consumer organizations, health systems, and other interested stakeholders that represent the myriad views of those involved in drug, biologic, and device discovery, development, translation, and regulation. The workshop audiences are expected to be similarly diverse, and they will have opportunities to engage in discussion during the workshops.
  • Improving Cancer Diagnosis and Care: The Clinical Application of Computational Methods in Precision Oncology: A Workshop Date: October 29, 2018 - October 30, 2018 (8:00 AM Eastern)

    The workshop will be held on October 29 – 30, 2018 to examine the clinical use of high-dimensional omics data and computational methods in precision oncology research and clinical care.